Vandana Yadav

Vandana Yadav

Auto-generated profile, based on publicly available information

Vandana Yadav

Healthcare Innovation Technology Lab (HITLAB), Lasker Hall, 3960 Broadway, Room 501, New York, US

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in JMIR Formative Research
Verified
Journal Article
Open access
SCSara Chokshi
Sara Chokshi
GTGulzhan Tologonova
Gulzhan Tologonova
Rose CalixteRose Calixte
Rose Calixte
VYVandana Yadav
Vandana Yadav
NRNaveed Razvi
Naveed Razvi
SKStan Kachnowski
Stan Kachnowski
Background: Abnormal prolongation or shortening of the QT interval is associated with increased risk for ventricular arrhythmias and sudden cardiac death. For continuous monitoring, widespread use, and prevention of cardiac events, advanced wearable technologies are emerging as promising surrogates for conventional 12‑lead electrocardiogram (ECG) QT interval assessment. Previous studies have shown a good agreement between QT and corrected QT (QTc) intervals measured on a smartwatch ECG and a 12-lead ECG, but the clinical accuracy of computerized algorithms for QT and QTc interval measurement from smartwatch ECGs is unclear. Objective: The prospective observational study compared the smartwatch-recorded QT and QTc assessed using AccurKardia’s AccurBeat platform with the conventional 12‑lead ECG annotated manually by a cardiologist. Methods: ECGs were collected from healthy participants (without any known cardiovascular disease) aged >22 years. Two consecutive 30-second ECG readings followed by (within 15 minutes) a 10-second standard 12-lead ECG were recorded for each participant. Characteristics of the participants were compared by sex using a 2-sample t test and Wilcoxon rank sum test. Statistical comparisons of heart rate (HR), QT interval, and QTc interval between the platform and the 12-lead ECG, ECG lead I, and ECG lead II were done using the Wilcoxon sign rank test. Linear regression was used to predict QTc and QT intervals from the ECG based on the platform’s QTc/QT intervals with adjustment for age, sex, and difference in HR measurement. The Bland-Altman method was used to check agreement between various QT and QTc interval measurements. Results: A total of 50 participants (32 female, mean age 46 years, SD 1 year) were included in the study. The result of the regression model using the platform measurements to predict the 12-lead ECG measurements indicated that, in univariate analysis, QT/QTc intervals from the platform significantly predicted QT/QTc intervals from the 12-lead ECG, ECG lead I, and ECG lead II, and this remained significant after adjustment for sex, age, and change in HR. The Bland-Altman plot results found that 96% of the average QTc interval measurements between the platform and QTc intervals from the 12-lead ECG were within the 95% confidence limit of the average difference between the two measurements, with a mean difference of –10.5 (95% limits of agreement –71.43, 50.43). A total of 94% of the average QT interval measurements between the platform and the 12-lead ECG were within the 95% CI of the average difference between the two measurements, with a mean difference of –6.3 (95% limits of agreement –54.54, 41.94). Conclusions: QT and QTc intervals obtained by a smartwatch coupled with the platform’s assessment were comparable to those from a 12-lead ECG. Accordingly, with further refinements, remote monitoring using this technology holds promise for the identification of QT interval prolongation.

25 November 2024 in JMIR Formative Research
Verified
Journal Article
Open access
EJEkta Jain
Ekta Jain
SGSrishti Gupta
Srishti Gupta
VYVandana Yadav
Vandana Yadav
SKStan Kachnowski
Stan Kachnowski
Background: Telemedicine has revolutionized health care by significantly enhancing accessibility and convenience, yet barriers remain, such as providers’ challenges with technology use. With advancements in telemedicine technologies, understanding the viewpoints of patients and providers is crucial for an effective and acceptable telemedicine service. This study reports the findings on the usability and effectiveness of the HelixVM artificial intelligence powered platform, analyzing key aspetcs like asynchronous health care, access, time efficiency, productivity, data exchange, security, privacy, and quality of care from patient and provider perspectives. Objective: This study aims to assess the usability and effectiveness of the HelixVM marketplace platform. Methods: We recruited 102 patients and 12 providers in a mixed methods study design involving surveys and in-depth structured interviews with a subset of the providers. The survey questionnaires are a modified version of the Telehealth Usability Questionnaire. We analyzed patient data using descriptive statistics and exploratory factor analysis to identify latent demographic patterns. For provider data, we used a deductive thematic analysis approach to identify key themes from the interviews and interpreted overall sentiments of the providers as negative, neutral, or positive. We also calculated percentages of different provider responses from the survey and interviews, where applicable. Results: Overall, 86.3% (88/102) of the patients reported satisfaction with HelixVM, and 89.2% (91/102) indicated that they would use the services again. A total of 91.1% (93/102) of the patients agreed that HelixVM improves access to health care and is an acceptable way to receive health care, and 98% (100/102) agreed it saves time. Chi-square tests demonstrated statistical significance for all survey questions (P<.001). The results from factor analysis show a higher propensity of middle-aged women, who had a fast-track encounter type, who self-reported a medium level of technology savviness, and who are residing in the South region of the United States rating the platform more positively. With regard to the providers, the thematic analysis identified themes of asynchronous medicine in terms of the accessibility and quality of care, time and productivity, integration within the workflow, data exchange, and artificial intelligence triage. Certain challenges regarding incomplete data in patient charts and its impact on provider time were cited. Suggestions for improvements included options to ensure the completeness of patient charts and better screening to ensure that only asynchronous, qualified patients are able to reach the provider. Conclusions: Overall, our study findings indicate a positive experience for patients and providers. The use of fast-track prescription was considered favorable compared to traditional telemedicine. Some concerns on data completeness, gaps, and accuracy exist. Suggestions are provided for improvement. This study adds to the knowledge base of existing literature and provides a detailed analysis of the real-world implementation of a telemedicine market-place platform.

31 May 2024 in JMIR Preprints
Verified
Preprint
Open access
EJEkta Jain
Ekta Jain
SGSrishti Gupta
Srishti Gupta
VYVandana Yadav
Vandana Yadav
SKStan Kachnowski
Stan Kachnowski
BACKGROUND Telemedicine has revolutionized health care by significantly enhancing accessibility and convenience, yet barriers remain, such as providers’ challenges with technology use. With advancements in telemedicine technologies, understanding the viewpoints of patients and providers is crucial for an effective and acceptable telemedicine service. This study reports the findings on the usability and effectiveness of the HelixVM artificial intelligence powered platform, analyzing key aspetcs like asynchronous health care, access, time efficiency, productivity, data exchange, security, privacy, and quality of care from patient and provider perspectives. OBJECTIVE This study aims to assess the usability and effectiveness of the HelixVM marketplace platform. METHODS We recruited 102 patients and 12 providers in a mixed methods study design involving surveys and in-depth structured interviews with a subset of the providers. The survey questionnaires are a modified version of the Telehealth Usability Questionnaire. We analyzed patient data using descriptive statistics and exploratory factor analysis to identify latent demographic patterns. For provider data, we used a deductive thematic analysis approach to identify key themes from the interviews and interpreted overall sentiments of the providers as negative, neutral, or positive. We also calculated percentages of different provider responses from the survey and interviews, where applicable. RESULTS Overall, 86.3% (88/102) of the patients reported satisfaction with HelixVM, and 89.2% (91/102) indicated that they would use the services again. A total of 91.1% (93/102) of the patients agreed that HelixVM improves access to health care and is an acceptable way to receive health care, and 98% (100/102) agreed it saves time. Chi-square tests demonstrated statistical significance for all survey questions (P<.001). The results from factor analysis show a higher propensity of middle-aged women, who had a fast-track encounter type, who self-reported a medium level of technology savviness, and who are residing in the South region of the United States rating the platform more positively. With regard to the providers, the thematic analysis identified themes of asynchronous medicine in terms of the accessibility and quality of care, time and productivity, integration within the workflow, data exchange, and artificial intelligence triage. Certain challenges regarding incomplete data in patient charts and its impact on provider time were cited. Suggestions for improvements included options to ensure the completeness of patient charts and better screening to ensure that only asynchronous, qualified patients are able to reach the provider. CONCLUSIONS Overall, our study findings indicate a positive experience for patients and providers. The use of fast-track prescription was considered favorable compared to traditional telemedicine. Some concerns on data completeness, gaps, and accuracy exist. Suggestions are provided for improvement. This study adds to the knowledge base of existing literature and provides a detailed analysis of the real-world implementation of a telemedicine market-place platform.

15 September 2026 in JMIR Preprints
Verified
Preprint
Open access
SCShruti Chopra
Shruti Chopra
VYVandana Yadav
Vandana Yadav
NSNeal Sikka
Neal Sikka
RHRachel Harbut
Rachel Harbut
SKStan Kachnowski
Stan Kachnowski
LFLisa Fitzpatrick
Lisa Fitzpatrick
BACKGROUND Low health literacy impacts Americans from all walks of life. A recent national survey revealed over 60% of US adults demonstrate inadequate health literacy, and this is independently associated with lower preventive care utilization, poorer chronic disease management, and higher healthcare costs. Despite growing interest in digital health education, little is known about the impact of health education video content. To better understand the receptivity to a unique video-based approach to health education, this study evaluated the impact of brief, short-form physician–community member dialogue videos. OBJECTIVE To evaluate the acceptability of a short-form physician–community member dialogue video series, including content comprehension, perceived quality and trustworthiness, behavioral intentions, and stated willingness to share the content among U.S. adults. METHODS A cross-sectional, within-subjects observational evaluation was conducted online via HITLAB's survey platform. One hundred validated U.S. adults were recruited through a five-stage screening process and completed a pre-video questionnaire, viewed six sequential short-form educational videos, and completed a post-video questionnaire assessing perceived learning, content quality, trustworthiness, behavioral intentions, and willingness to share the content. All analyses were descriptive. RESULTS Participants were predominantly aged 45–54 years (64%), with 56% female and 79% having visited a healthcare provider in the preceding six months. Educational attainment was heterogeneous, with 25% holding below a high school diploma and 62% holding an undergraduate or graduate degree. Despite moderate-to-high baseline awareness, 99% of participants found the videos informative and 96% reported learning something new. Participants demonstrated high levels of comprehension of the educational content. Behavioral intent was similarly strong, with 91% likely to follow advice and 90% likely to take action. The series achieved an NPS of +41, exceeding the 2026 healthcare industry average of +37, with a 3.7:1 promoter-to-detractor ratio and a mean sharing score of 9.1/10. However, the present study did not measure actual sharing, reach, or social-network diffusion. CONCLUSIONS The short-form physician–community member dialogue video format was well accepted and received favorable ratings for comprehension, trustworthiness, and content quality. Participants also reported perceived learning, positive behavioral intentions, and willingness to share the videos. These findings support further evaluation of the format as a potentially scalable approach to digital health education. Longitudinal studies are needed to determine whether these responses translate into sustained knowledge and actual preventive health behaviors. CLINICALTRIAL N/A

12 September 2021 in JMIR Preprints
Verified
Preprint
Open access
SCSara Chokshi
Sara Chokshi
YSYalini Senathirajah
Yalini Senathirajah
VYVandana Yadav
Vandana Yadav
MWMimi Winsberg
Mimi Winsberg
EOErin O'Callaghan
Erin O'Callaghan
SKStan Kachnowski
Stan Kachnowski
UNSTRUCTURED Objective: Over 20% of US adults live with a mental illness, and the more prevalent conditions of depression and anxiety are typically managed in primary care settings rather than specialty care. The aim of this study is to determine the efficacy of a novel, measurement-driven psychiatric treatment platform delivered via an online platform (Brightside) as compared to treatment as usual (TAU). Methods: The TAU dataset and the Brightside dataset were constructed from the total populations of adult patients receiving care for depression from January 2018 through December 2020 (November 2018 through March 2021 for the Brightside group). Patients in both groups had a primary mental health diagnosis of depression and/or anxiety, and presence of a positive screen for depression or anxiety as measured by the PHQ-9 upon initiation of treatment. HITLAB, an independent digital health verification and testing lab, conducted comparative analyses of the two groups using chi square test of independence. Results: Close to 80% of Brightside patients experienced a 5 or more points reduction in their baseline PHQ9 score as compared to 52% of TAU patients. The mean reduction in PHQ9 score was slightly higher in the Brightside group (-11.5) versus the TAU group (-10.1). Chi-square tests of independence x2 (1, N=6281) = 256.75, p<=0.001 for meaningful reduction and for remission (x2 (1, N=6281) = 105.50 p<=0.001 are highly significant. Conclusion: Brightside performed significantly better than psychiatric treatment as usual in reducing symptoms of depression and anxiety in adults.